Karen Kaucic

President, Patient and Advisory Services & Chief Medical Officer, Clinical Research, PPD, Part of Thermo Fisher Scientific

Karen Kaucic, M.D., serves as president of patient and advisory services and as chief medical officer for the PPD clinical research business of Thermo Fisher Scientific.
As president of patient and advisory services, she oversees two primary business functions: direct-to-patient (DTP) services and advisory services. The former includes responsibility for three early phase clinics, a 150-site late phase network, and digital and decentralized solutions. The latter includes responsibility for medical science and strategy; a medical information contact center; Evidera, a global leader in real-world evidence and data analytics, health economics, patient-centered research and strategic consultation services in medical science, clinical development and market access; and CorEvitas, a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies.

As chief medical officer, Karen is responsible for all aspects of human safety policies and processes in all DTP business. She also is responsible for developing strategies to advance the DTP business and in that capacity works closely with the corporate strategy group of the PPD clinical research business to develop or acquire solutions to advance its clinical products and services.

At various times in previous roles with the business, Karen led Evidera, early development services and the PPD® Consulting product development consulting group. Prior to that, Karen held positions of increasing responsibility in oncology clinical development at MedImmune and AstraZeneca. There, she led product development teams for several biologic compounds across a range of oncology indications.

Earlier in her career, Karen was a staff pediatric oncologist and senior investigator at Children’s National Medical Center in Washington, D.C., where she established and led the institution’s first hematopoietic stem cell transplantation laboratory, served as an attending physician in pediatric stem cell transplantation and oncology, and conducted research funded by the National Institutes of Health in signal transduction in human neuroectodermal tumors.

Karen earned her medical degree from The Ohio State University followed by a pediatric residency at the same institution. She completed fellowships in pediatric hematology/oncology and transfusion medicine at Children’s National Medical Center and The Cleveland Clinic, respectively.

Karen Kaucic is a part of the PPD. Learn More
Scroll to Top